Please login to the form below
DAM and CMS: managing assets to maximise adoption and value
Senior Account Executive Dave Wood talks us through what DAM and CMS are, the role they play in the future of healthcare marketing, and how they can be best utilised to maximise outcomes for pharma and agencies.
As we watch the world of
healthcare marketing shift
into the digital era, we see new opportunities beginning to emerge for pharma
to target their customers with novel, exciting and innovative content.
Alongside this shift, there is the growing need to deliver this content in the
quickest way possible. This digital
revolution is setting the
scene for a faster, cleaner and more effective use of marketing content, which
minimises time and cost without compromising on quality.
While we look towards the possibilities that this transition offers, so too must we look at the systems that will be supporting the delivery and uptake of these files – this is where digital asset management (DAM) and content management systems (CMS) come into the mix.
Senior Account Executive Dave Wood talks us through what DAM and CMS are, the role they play in the future of healthcare marketing, and how they can be best utilised to maximise outcomes for pharma and agencies.
What is DAM and who uses it?
Digital asset management (DAM) is a system that supports the distribution of digital assets among users. It is the bridge that delivers revolutionary, breakthrough information to continually content-hungry users. In this industry, any stakeholder within the complex network of healthcare could be a user, and it’s these connections between users where DAM has the opportunity to thrive.
What is a CMS and how is it different from DAM?
When discussing DAM, it is necessary to recognise the role of content management systems (CMS) and understand the difference between the two. While DAM supports the delivery of assets between users, CMS facilitates the uptake and use of these assets. For example, a DAM system would allow an advertising agency to deliver an advert to multiple media publishers throughout a region. A CMS then informs those publishers of how to edit and format the adverts for their different channels, as well as how to apply search criteria so that their customers can view the adverts easily.
How can we use DAM/CMS?
The two systems work together to provide insight into the true value of an asset, by demonstrating how it is being used across a network of users. Furthermore, DAM/CMS systems are continuing to evolve alongside the development of technology, resulting in an expansion in the types of assets that can be shared across networks. This growth fuels the competitiveness of the industry by encouraging users to share the most ground-breaking and high quality assets in the quickest time possible. The question is: what makes the systems worthy of the investment in the first place, and what value do the users gain?
![]()
While we look towards the possibilities that this transition offers, so too must we look at the systems that will be supporting the delivery and uptake of these files – this is where digital asset management (DAM) and content management systems (CMS) come into the mix.
Senior Account Executive Dave Wood talks us through what DAM and CMS are, the role they play in the future of healthcare marketing, and how they can be best utilised to maximise outcomes for pharma and agencies.
What is DAM and who uses it?
Digital asset management (DAM) is a system that supports the distribution of digital assets among users. It is the bridge that delivers revolutionary, breakthrough information to continually content-hungry users. In this industry, any stakeholder within the complex network of healthcare could be a user, and it’s these connections between users where DAM has the opportunity to thrive.
What is a CMS and how is it different from DAM?
When discussing DAM, it is necessary to recognise the role of content management systems (CMS) and understand the difference between the two. While DAM supports the delivery of assets between users, CMS facilitates the uptake and use of these assets. For example, a DAM system would allow an advertising agency to deliver an advert to multiple media publishers throughout a region. A CMS then informs those publishers of how to edit and format the adverts for their different channels, as well as how to apply search criteria so that their customers can view the adverts easily.
How can we use DAM/CMS?
The two systems work together to provide insight into the true value of an asset, by demonstrating how it is being used across a network of users. Furthermore, DAM/CMS systems are continuing to evolve alongside the development of technology, resulting in an expansion in the types of assets that can be shared across networks. This growth fuels the competitiveness of the industry by encouraging users to share the most ground-breaking and high quality assets in the quickest time possible. The question is: what makes the systems worthy of the investment in the first place, and what value do the users gain?
Download the full article from Blue Latitude Health
Company Details
Blue Latitude Health
+44 203 328 1840
Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom
Latest content on this profile
- Understanding COVID-19 and varying responses across the globe
- At the beginning of the COVID-19 Pandemic, Senior Account Executive Lauren Fernandes took a course at the London School of Hygiene and Tropical Medicine to better understand how the global response to the virus and to ensure we were best positioned to serve our clients during this challenging time. She shares the key learnings and why understanding the epidemiology of the disease is integral for fighting it.
Blue Latitude Health
- Top 5 tips for a multi-indication product launch
- Senior Associate Consultant Sana Rahim and Senior Consultant Victoria Clark explain the lessons the team has learned from launching six different indications of an oncology product in an accelerated timeframe.
Blue Latitude Health
- If our patients are diverse, why are clinical trials so white?
- Despite facing worse health outcomes, minority populations are often left out of clinical trials and miss the opportunity to participate in life-saving research. Associate Consultant Ling Song explores this issue and calls for the pharmaceutical industry to change its approach.
Blue Latitude Health
- Engaging physicians during COVID-19
- COVID-19 has drastically changed the lives of healthcare professionals. They are emotionally and physically drained and under huge amounts of pressure. They also need pharma’s help. Senior Consultant Pany Koizi outlines five principles for engaging with physicians during the pandemic.
Blue Latitude Health
- Fishawack Health adds market access and commercial strategy consultancy Skysis as part of its bold growth plans
- Fishawack Health, the global healthcare communications agency, announces the acquisition of Skysis, a boutique consulting firm providing integrated market access and commercial strategy solutions based in the US.
Blue Latitude Health
- Perspective: the patient edition
- In this issue of Perspective magazine, we explore how the industry can place a greater emphasis on patient-centricity, and how pharmaceutical companies are working with patients across the product lifecycle to develop therapies that better serve their unmet needs.
Blue Latitude Health
